Vera Therapeutics Inc logo

Vera Therapeutics Inc

VERA
Healthcare|Biotechnology|USA
$42.00
-0.45 (-1.06%)
Tangible Book
$6.97
Earnings Power
$7.21

Upcoming Data Readouts (3)

Sep 2026
Est. completion
P2IgA Nephropathy (IgAN)
Monthly Dosing of Atacicept in IgAN
NCT07020923n=90
Dec 2026
Est. completion
NAAnxiety
Effect of Virtual Reality Use on Preoperative Anxiety
NCT07270445n=172
Nov 2027
Est. completion
P2pMN
Atacicept in Multiple Glomerular Diseases
NCT06983028n=250

Awaiting Results (1)

Trials past primary completion date but still active — data readout may be imminent.

May 2025
P3
Atacicept in Subjects With IgA Nephropathy
NCT04716231

Recent Press Releases